Objectives: The quality of care for dementia in acute-care settings has been criticised. In 2016, the Japanese universal health insurance system introduced a financial incentive scheme for dementia care by dementia specialist teams in acute-care hospitals. This study aimed to investigate the effectiveness of this financial incentive scheme on short-term outcomes (in-hospital mortality and 30-day readmission).

Design And Methods: Using a Japanese nationwide inpatient database, we identified older adult patients with moderate-to-severe dementia admitted for pneumonia, heart failure, cerebral infarction, urinary tract infection, intracranial injury or hip fracture from April 2014 to March 2018. We selected 180 propensity score-matched pairs of hospitals that adopted (n = 180 of 185) and that did not adopt (n = 180 of 744) the financial incentive scheme. We then conducted a patient-level difference-in-differences analysis. In a sensitivity analysis, we restricted the postintervention group to patients who actually received dementia care.

Results: There was no association between a hospital's adoption of the incentive scheme and in-hospital mortality (adjusted odds ratio [aOR]: 0.97; 95% confidence interval [CI]: 0.88-1.06; p = 0.48) or 30-day readmission (aOR: 1.04; 95% CI: 0.95-1.14; p = 0.37). Only 29% of patients in hospitals adopting the scheme actually received dementia care. The sensitivity analysis showed that receiving dementia care was associated with decreased in-hospital mortality.

Conclusions: The financial incentive scheme to enhance dementia care by dementia specialist teams in Japan may not be working effectively, but the results do suggest that individual dementia care was associated with decreased in-hospital mortality.

Download full-text PDF

Source
http://dx.doi.org/10.1002/gps.5537DOI Listing

Publication Analysis

Top Keywords

incentive scheme
24
dementia care
24
financial incentive
20
care dementia
16
dementia
12
dementia specialist
12
specialist teams
12
in-hospital mortality
12
scheme dementia
8
teams acute-care
8

Similar Publications

Using citizen science for the energy transition: Research on the tenant electricity model in Germany.

Open Res Eur

January 2025

Women Engage for a Common Future, Munich, Bavaria, 80331, Germany.

Background: The research within the Citizen Science (CS) project on tenant electricity focused on an inclusive research approach by involving actors such as citizen scientists (CSs), scientists, policymakers, and the private sector. The main objective was to jointly explore the barriers and drivers for and motivations to participate in the tenant electricity model in Germany, and to identify behavioural changes (based on the energy culture concept) of the CSs by being involved in local electricity production and consumption.

Methods: The CS project adopted a mixed-method approach, combining qualitative data analysis from workshops with quantitative data from an energy consumption monitoring scheme and a panel survey on energy-related practices.

View Article and Find Full Text PDF

Mixed remuneration schemes with capitation and fee-for-service (FFS) payments hold financial incentives to add patients to the list and provide services to listed patients. However, as patients with complex needs tend to require longer consultations there is a risk of inequality in access if fees are not adjusted to patient characteristics. In this paper, we assess a natural experiment introducing additional capitation for GPs with a high share of complex patients (moderate scheme) and for GPs in certain geographical areas (intensive scheme).

View Article and Find Full Text PDF

Purpose: This paper attempts to elucidate the fundamental determinants-both enablers and impediments-that shape a resilient business ecosystem for the medical devices sector in India, with a particular emphasis on sustainable export endeavours under the ambit of the Medical Devices Policy 2023.

Design/methodology/approach: This study dives into India's medical device export firms, analysing factors influencing their performance. By reviewing relevant literature, it identifies regulatory, manufacturing, marketing, distribution and import-related factors.

View Article and Find Full Text PDF

Background: Ensuring timely and equitable access to effective and optimal antimicrobials is crucial for optimal patient care, to minimize the use of less appropriate treatment options and reduce the risk of antimicrobial resistance (AMR).

Objectives: To determine the average time for new antibacterials to gain registration for use in Australia after obtaining marketing approval internationally, and to quantify the use of 'new' and older unregistered antimicrobials in Australian clinical practice between 2018 and 2023.

Methods: Two data sources were utilized to estimate the usage of antimicrobials not registered for use in Australia.

View Article and Find Full Text PDF

In Thailand, the recurring environmental issue of high PM2.5 concentrations from December to April is partly due to pre-harvest sugarcane burning. This practice severely impacts the environment, economy, and public health.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!